---
title: "Cryotherapy versus topical anesthetics for injection pain and compliance in children: randomized t"
id: "plos-one-11-pain-sensory-acceptability-and-treatment-compliance-following-cryotherapy-and"
canonical_url: "https://medichelpline.com/clinical-feed/plos-one-11-pain-sensory-acceptability-and-treatment-compliance-following-cryotherapy-and"
content_type: "clinical_feed_article"
specialty: "Dentistry"
source_name: "PLOS ONE (Medicine)"
source_url: "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362074"
published_at: "2026-11-03T14:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Cryotherapy versus topical anesthetics for injection pain and compliance in children: randomized t
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/plos-one-11-pain-sensory-acceptability-and-treatment-compliance-following-cryotherapy-and
- **Specialty:** [Dentistry](https://medichelpline.com/clinical-feed/dentistry.md)
- **Primary Source:** PLOS ONE (Medicine)
- **Source URL:** [Original Journal Publication](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362074)
- **Published At:** 2026-11-03T14:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- Randomized, single-blinded trial enrolled 100 healthy children aged 7–10 years; participants were allocated equally into four parallel groups (n = 25 per group). - Interventions compared: 10% **lidocaine** spray, 20% **benzocaine** gel, **cryotherapy** with distilled water at +4 °C, and cooled 10% **lidocaine** spray at +4 °C. All agents were applied with a cotton pellet for 20 seconds before buccal infiltration. - Buccal infiltration anesthesia used 4% articaine with 1:100,000 epinephrine; 1.5 mL deposited slowly using a 27-gauge needle; physiological measures recorded at needle penetration. - Primary outcome: pain during injection measured by the **Wong-Baker FACES Pain Rating Scale**; secondary outcomes: dental anxiety (Modified Dental Anxiety Scale and Facial Image Scale), pulse rate and oxygen saturation (pulse oximeter), taste acceptability (Three-Point Hedonic Scale), and treatment compliance (FRANKL Behavior Rating Scale). - Statistical methods: repeated-measures ANOVA for physiological variables; Kruskal-Wallis and Mann-Whitney U tests for ordinal/non-normally distributed outcomes; significance threshold p 0.05 for these comparisons). Pulse rate rose from pre-operative to post-operative periods across all groups (p = 0.006), with no group × time interaction. - The cryotherapy (distilled water) group had higher FRANKL scores versus the gel and cooled-spray groups (p = 0.001); authors described this as an exploratory finding. - Trial registration: ClinicalTrials.gov NCT07198022. Ethics approvals and informed consent were obtained; no adverse events reported. Authors recommend confirmation in non-inferiority trials before routine clinical adoption of cryotherapy for injection anesthesia in children.
## Clinical Analysis & Structured Key Points
Pain, sensory acceptability, and treatment compliance following cryotherapy and topical anesthetics in children: A randomized clinical trial | PLOS One Browse Subject Areas ? Click through the PLOS taxonomy to find articles in your field. For more information about PLOS Subject Areas, click here . Article Authors Metrics Comments Media Coverage Peer Review Reader Comments Figures Figures Abstract This randomized clinical trial aimed to compare the effects of cryotherapy, anesthetic spray, and gel on pain, anxiety, physiological responses, taste acceptability, and treatment compliance in children aged 7–10 years undergoing their first dental treatment. 100 healthy children were randomly allocated into four groups: 10% lidocaine spray, 20% benzocaine gel, cryotherapy with distilled water cooled to +4 °C, and lidocaine spray cooled to +4 °C. Following topical application, buccal infiltration anesthesia was administered. Anxiety, pain, and physiological responses were assessed using the Modified Dental Anxiety Scale and Facial Image Scale, Wong-Baker FACES Pain Rating Scale, and pulse-oximeter. Taste acceptability and treatment compliance were evaluated using a three-point Hedonic Scale and the FRANKL Scale. Repeated Measures ANOVA, Mann-Whitney U, and Kruskal-Wallis tests were applied. No significant differences were observed among the groups in anxiety, pain, pulse rate, oxygen saturation, or taste acceptability (p > 0.05). Pulse rate increased from the pre-operative to the post-operative period in all groups (p = 0.006), with no significant group × time interaction. FRANKL scores were significantly higher in the cryotherapy-distilled water group compared with the gel and cooled-spray groups (p = 0.001), a finding considered exploratory. Pain and anxiety outcomes following cryotherapy did not differ significantly from those of the topical anesthetic agents, while treatment compliance was higher, suggesting that cryotherapy may be a promising non-pharmacological option, pending confirmation in non-inferiority trials. Trial registration ClinicalTrials.gov NCT07198022 Citation: Aydın Çetin EZ, Özmen B (2026) Pain, sensory acceptability, and treatment compliance following cryotherapy and topical anesthetics in children: A randomized clinical trial. PLoS One 21(11): e0362074. https://doi.org/10.1371/journal.pone.0362074 Editor: Aline Castilho, Indiana University School of Dentistry, UNITED STATES OF AMERICA Received: August 4, 2026; Accepted: October 19, 2026; Published: November 3, 2026 Copyright: © 2026 Aydın Çetin, Özmen. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data Availability: We confirm that the submission contains the minimal data set required to replicate all reported findings, provided in S1 Dataset (S1_Dataset.xlsx; de-identified individual participant data with data dictionary). Funding: The author(s) received no specific funding for this work. Competing interests: The authors have declared that no competing interests exist. Introduction During dental treatments, the most stressful and anxiety-inducing factor, and the most common reason for missing or postponing appointments, is the fear of pain and injury from injections. This condition, frequently encountered in childhood, tends to persist into later life. One in four adults has an injection phobia, and one in 20 patients avoids dental treatment due to this phobia [ 1 ]. In pediatric patients, intense resistance to injections, hysterical reactions, and anxiety attacks may hinder the delivery of planned dental care, ultimately leading to untreated caries and a consequent decline in oral health-related quality of life [ 1 – 3 ]. To minimize discomfort and improve patient cooperation, topical anesthetics are routinely applied before needle insertion, aiming to reduce pain perception at the injection site and provide both psychological and physical relief [ 4 ]. The rationale for this approach is grounded in the neurophysiological mechanisms underlying dental pain transmission. Tooth innervation is mediated by branches of the trigeminal nerve (the fifth cranial nerve), specifically the maxillary nerve (n. maxillaris) in the maxilla and the mandibular nerve (n. mandibularis) in the mandible [ 5 ]. Nociceptive stimuli originating from dental tissues activate peripheral nociceptors, triggering the generation and propagation of action potentials along sensory neurons. This process is primarily governed by voltage-gated sodium channels, which play a central role in neuronal excitability and pain signaling [ 5 , 6 ]. Local anesthetics achieve their analgesic effect by reversibly blocking voltage-gated sodium channels, thereby preventing sodium influx and inhibiting both the initiation and propagation of action potentials. By interrupting nociceptive signal transmission at the peripheral nerve level, these agents effectively reduce pain perception during dental procedures [ 7 , 8 ]. However, the injection itself may cause discomfort, as commercial local anesthetic solutions, particularly those containing epinephrine, are formulated at an acidic pH to prolong shelf life, which is considered one of the causes of the burning sensation experienced during injection [ 9 ]. In this context, topical anesthetics are widely recommended prior to injection, particularly in children and anxious patients, as a supportive strategy to attenuate superficial nociceptive input and enhance comfort during local anesthetic administration [ 4 ]. Pain and anxiety are multidimensional experiences influenced by both psychological and physiological factors [ 10 , 11 ]. While self-reported scales provide valuable insight into subjective pain perception and emotional responses, physiological parameters, such as pulse rate and oxygen saturation, serve as objective markers of autonomic nervous system activation during dental procedures [ 11 – 13 ]. Recently, cryotherapy has gained increasing popularity as a non-pharmacological technique for alleviating post-operative pain [ 14 ]. In dentistry, cryotherapy has been used as an adjunctive pain management strategy following tooth extractions, periodontal surgical procedures, and implant surgeries [ 15 ]. Beyond post-operative applications, cryotherapy has also been explored as an alternative topical anesthetic. A recent systematic review and meta-analysis by Saeedi et al. synthesized the available randomized evidence on cryotherapy and topical anesthetics for intraoral injection pain, reporting that these approaches may reduce injection-related discomfort [ 16 ]. Moreover, cryotherapy has also been reported to improve pulpal anesthesia success rates in adolescent patients undergoing endodontic treatment, supporting its broader analgesic potential in dental practice [ 17 ]. Nevertheless, the available evidence has largely focused on pain outcomes, leaving the broader sensory and behavioral dimensions of these interventions, such as taste acceptability and treatment compliance, insufficiently addressed in the literature. In dental settings, pediatric patients commonly exhibit a natural avoidance of materials that induce unpleasant sensory experiences, such as pain, burning sensations, or unfavorable taste. These sensory perceptions may significantly influence children's acceptance of dental procedures and their willingness to cooperate during treatment [ 18 ]. Children's behavioral responses and treatment compliance are equally important clinical outcomes alongside pain reduction, yet the impact of topical anesthetic agents and cryotherapy on these dimensions remains insufficiently investigated. Despite the widespread use of these agents in pediatric dentistry, no study to date has systematically evaluated taste acceptability and treatment compliance alongside pain outcomes in a comparative four-arm design. Therefore, this study aimed to evaluate the effects of cryotherapy compared with routinely used topical anesthetic agents on injection-related pain, taste acceptability, and treatment compliance in pediatric patients, alongside dental anxiety and physiological responses, to provide a more comprehensive assessment of the pediatric patient experience extending beyond pain measurement to incorporate sensory and behavioral dimensions. Materials and Methods Study design and ethical approval This randomized clinical trial was conducted at the Department of Pediatric Dentistry, Ondokuz Mayıs University. The study protocol was approved by the Ondokuz Mayıs University Clinical Research Ethics Committee (Approval No: 2024/316) and the Turkish Medicines and Medical Devices Agency (No: E-24931227-514.04.02-5719207). The trial was registered at ClinicalTrials.gov (NCT07198022) and conducted in accordance with the principles of the Declaration of Helsinki. Participants were recruited between 25/09/2025 and 15/01/2026. Written informed consent was obtained from both children and their legal guardians before enrollment. Sample size calculation Sample size was calculated using G*Power (version 3.1.9.7) with the “ANOVA: Fixed effects, omnibus, one-way” procedure for four independent groups. An effect size of Cohen's f = 0.50 was estimated from the means and standard deviations of pain scores reported by Dhingra et al. [ 19 ]. Assuming α = 0.05 and a power of 95%, the minimum required total sample size was 76 participants (19 per group). To compensate for potential dropouts, 100 participants (25 per group) were enrolled. Participants and eligibility criteria Children aged 7–10 years who were literate, classified as ASA physical status I-II, exhibited positive behavior (FRANKL scores 3–4), and had a Modified Dental Anxiety Scale (MDAS) score < 19 were eligible for inclusion. Additional inclusion criteria were an indication for treatment of primary teeth, no known allergy to the active ingredients of the topical anesthetic agents, and no prior dental treatment experience. Children who otherwise met the inclusion criteria were excluded if the tooth to be treated was symptomatic (spontaneous or acute pain, swelling, or a sinus tract). Accordingly, all included children were asymptomatic at the time of treatment, and the indicated treatments included restorative treatment, pulpotomy, or extraction of primary maxillary molars. Randomization and blinding Eligible participants were randomly allocated to four parallel groups (n = 25 per group) using sequentially numbered opaque sealed envelopes prepared by an independent researcher to ensure allocation concealment. Participants were not informed of the existence of the alternative interventions and had no prior dental treatment experience, so they encountered the assigned agent without any basis for comparison and were unaware of their group allocation. Due to the distinct physical characteristics of the topical materials, operator blinding was not feasible. Therefore, the study was designed as a single-blinded randomized clinical trial, in which participants were blinded to group allocation. Outcome assessments were performed by an independent evaluator blinded to the intervention groups, constituting an assessor-blinded design. Interventions Participants were allocated to one of four intervention groups: Group 1: Application of 10% lidocaine hydrochloride topical spray (Locanest®, Avixa İlaç San. ve Tic. Ltd. Şti., Turkey). Group 2: Application of 20% benzocaine topical gel with strawberry flavor (Vision®, Anadolu Diş Deposu San. ve Tic. A.Ş., Turkey). Group 3: Application of cryotherapy using distilled water stored at +4 °C and applied immediately after removal from refrigeration. Group 4: Application of cooled topical anesthetic spray (10% lidocaine hydrochloride, Locanest®) stored at +4 °C prior to application. All topical agents were applied to the dried mucosal surface using a cotton pellet, gently pressed onto the injection site for 20 seconds, and followed by verbal confirmation of perceived numbness by the child prior to injection. After the patients confirmed adequate topical anesthesia, buccal infiltration anesthesia in the maxillary molar region was administered by a single operator using 4% articaine hydrochloride with 1:100,000 epinephrine (Ultraver D-S Forte, Haver, Turkey). A 2-mL disposable syringe (Ayset, Turkey) with a 27-i, 1½-inch (38-mm) needle was used, and 1.5 mL of anesthetic solution was deposited slowly, approximately 60 seconds. For standardization, physiological measurements recorded during injection were obtained at the moment of initial needle penetration, before anesthetic solution deposition. Outcome measures The primary outcome was pain perception during local anesthetic injection, assessed using the Wong-Baker FACES Pain Rating Scale (WBPRS) Secondary outcomes included: Dental anxiety, assessed using the Modified Dental Anxiety Scale (MDAS) and Facial Image Scale (FIS) Treatment compliance, assessed using the FRANKL Behavior Rating Scale during local anesthetic injection. Taste acceptability, assessed using the Three-Point Hedonic Scale Changes in physiological parameters (pulse rate and oxygen saturation), measured using a pulse oximeter (G-Life YK-80B, Xuzhou Yongkang Electronic Science Technology Co., Ltd., China) at three time points: before topical application (pre-operative), during topical application (peri-operative), and during local anesthetic injection (post-operative). CONSORT flow of participants No participants were excluded after randomization. All randomized participants received the allocated intervention, completed the study protocol, and were included in the final analysis. Additionally, no adverse events were observed in any participant during or immediately after the procedures. The flow of participants through the study phases was reported in accordance with the CONSORT guidelines [ 20 ]. Statistical analysis All statistical analyses were performed using IBM SPSS Statistics version 21.0 (IBM Corp., Armonk, NY, USA). The distribution of continuous variables was assessed using the Shapiro-Wilk test. Pulse rate and oxygen saturation, which met the assumption of normality, were analysed using a two-way repeated-measures analysis of variance (ANOVA), with measurement period (baseline, topical application, injection) as the within-subject factor and group as the between-subject factor; the group × time interaction was included to test whether changes over time differed among the interventions. Sphericity was assessed using Mauchly's test, and the Greenhouse-Geisser correction was applied when the assumption was violated. Partial eta-squared (ηp²) was reported as the effect size. When a significant main effect of time was found, pairwise comparisons between measurement periods were performed with Bonferroni adjustment. Between-group differences were further examined using Tukey's HSD test and are presented as mean differences with 95% confidence intervals.Ordinal and non-normally distributed outcomes (MDAS, FIS, WBPRS, Three-Point Hedonic Scale, and FRANKL scores) were compared among the four groups using the Kruskal-Wallis test. Effect sizes were calculated as epsilon-squared (ε² = H/(n − 1)) for all Kruskal-Wallis analyses. Where a significant difference was found, pairwise comparisons were performed with Bonferroni adjustment. The Mann-Whitney U test was used to compare anxiety scores (MDAS and FIS) between girls and boys. Baseline age was compared across groups using one-way ANOVA, and sex distribution using the Pearson chi-square test. As the WBPRS is a 0–10 scale with equal intervals, pairwise mean differences with Tukey-adjusted 95% confidence intervals were additionally calculated to quantify the magnitude and precision of between-group differences in the primary outcome. Continuous variables are presented as mean ± standard deviation and ordinal variables as median (first-third quartile). Because medians of short ordinal scales may be identical across groups despite differences in score distributions, means with 95% confidence intervals are provided as supplementary descriptive statistics; all inferences were based on nonparametric tests. Secondary outcomes were considered exploratory, and no adjustment was made for multiple testing across outcomes. Exact p-values are reported, and statistical significance was set at p < 0.05. The de-identified individual participant data and data dictionary are provided as Supporting Information ( S1 Dataset ). Results The flow of participants through the study phases is presented in Fig 1 . A total of 100 individuals were included in the study (48 females and 52 males). Gender distribution was comparable across groups, with no statistically significant differences observed (Pearson chi-square, χ²(3) = 3.205, p = 0.361). Age profiles were also similar, with a mean age of approximately 8 years and no significant differences among groups (One-way ANOVA, F(3,96) = 0.822, p = 0.485). Baseline demographic characteristics by study group are summarized in Table 1 . Download: PNG larger image TIFF original image Table 1. Age and sex distribution of participants across the study groups. https://doi.org/10.1371/journal.pone.0362074.t001 Download: PNG larger image TIFF original image Fig 1. CONSORT flow diagram of participant recruitment. https://doi.org/10.1371/journal.pone.0362074.g001 Pulse rate values obtained during the pre-operative, peri-operative, and post-operative periods are presented in Table 2 . As Mauchly's test indicated a violation of sphericity (χ²(2) = 8.10, p = 0.017), Greenhouse-Geisser corrected results are reported. A significant main effect of time was observed (F(1.85, 177.50) = 5.56, p = 0.006, ηp² = 0.055). Bonferroni-adjusted pairwise comparisons showed that pulse rate increased significantly from baseline to injection (mean difference 4.45 beats/min, 95% CI 0.78–8.12; p = 0.012), whereas the differences between baseline and topical application (p = 0.185) and between topical application and injection (p = 0.287) were not significant. Neither the main effect of group (F(3, 96) = 1.23, p = 0.303, ηp² = 0.037) nor the group × time interaction (F(5.55, 177.50) = 1.10, p = 0.361, ηp² = 0.033) was significant, indicating that changes in pulse rate over time did not differ among the interventions. Between-group mean differences with 95% confidence intervals are presented in S1 Table . Download: PNG larger image TIFF original image Table 2. Pulse rate (beats/min) according to study groups and measurement periods. https://doi.org/10.1371/journal.pone.0362074.t002 Oxygen saturation values are presented in Table 3 . As the assumption of sphericity was violated (Mauchly's test, χ²(2) = 12.90, p = 0.002), Greenhouse-Geisser corrected results are reported. No significant main effect of time (F(1.78, 170.37) = 2.96, p = 0.061, ηp² = 0.030), main effect of group (F(3, 96) = 1.84, p = 0.144, ηp² = 0.054), or group × time interaction (F(5.32, 170.37) = 1.46, p = 0.202, ηp² = 0.044) was observed. Between-group mean differences with 95% confidence intervals are presented in S1 Table . Download: PNG larger image TIFF original image Table 3. Oxygen saturation (%) according to study groups and measurement periods. https://doi.org/10.1371/journal.pone.0362074.t003 Patient-reported outcome measures and behavioral assessment scores across the study groups are summarized in Table 4 . MDAS scores ranged from 5 to 14 across all groups. Intergroup comparisons did not reveal any statistically significant differences in anxiety levels as assessed by MDAS (H(3) = 1.725, p = 0.631, ε² = 0.017). Similarly, no statistically significant differences were observed among the groups in FIS scores (H(3) = 3.410, p = 0.333, ε² = 0.034). No significant differences in anxiety scores were observed between girls and boys (MDAS: U = 1124.0, Z = −0.86, p = 0.388;
## Related Clinical Research

- [Augmented reality reduced poor cooperation but had mixed effects on dental anxiety in children](https://medichelpline.com/clinical-feed/pubmed-43064823.md) (DOI: 10.1007/s00784-026-07286-9)
- [Habitual qat chewing and short-term response to conservative treatment for temporomandibular disor](https://medichelpline.com/clinical-feed/plos-one-8-habitual-qat-chewing-and-short-term-response-to-conservative-management-of.md)
- [Digital Intraoral Scanners Improve Dental Impressions and Practice Workflow](https://medichelpline.com/clinical-feed/off-the-cusp-0-how-digital-intraoral-scanners-are-transforming-dental-impressions.md)
- [Assessment and Intervention of Occupational Health Risks in Intelligent Chemical Production](https://medichelpline.com/clinical-feed/plos-one-14-intelligent-chemical-production-mode-occupational-health-risk-identification.md)
- [Preparation–need concordance and patient readiness in robot-assisted surgery: scoping review findi](https://medichelpline.com/clinical-feed/pubmed-43064872.md) (DOI: 10.1007/s11701-026-04217-4)

## Navigation
- [← Back to Dentistry Feed](https://medichelpline.com/clinical-feed/dentistry.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.